TY - JOUR AU - Mountzios, Giannis PY - 2018 TI - Adjuvant bevacizumab for resected non-small cell lung cancer: the end of an era? JF - Translational Lung Cancer Research; Vol 7, Supplement 2 (April 23, 2018): Translational Lung Cancer Research Y2 - 2018 KW - N2 - The field of adjuvant therapy for surgically resected non-small cell lung cancer (NSCLC) has remained practically unchanged for the last 10–15 years, since the results of several large randomized clinical trials evaluating the benefit of platinum-based chemotherapy after surgery were published (1-4). UR - https://tlcr.amegroups.org/article/view/20492